Overview
Thomas Hogan is an Oncologist in Morgantown, West Virginia. Dr. Hogan is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, Chromophobe Renal Cell Carcinoma, and Renal Cell Carcinoma (RCC).
His clinical research consists of co-authoring 11 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- MEDICARE PDP
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1 Medical Center Dr, Morgantown, WV 26506
1 Stadium Dr, Morgantown,, WV 26506
Additional Areas of Focus
Dr. Hogan has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
UPMC Hillman Cancer Center
Benjamin A. Nacev, MD, PhD, specializes in medical oncology and practices with the University of Pittsburgh Physicians, Department of Medicine. Dr. Nacev completed his medical education at Johns Hopkins University School of Medicine and is board certified in Medical Oncology by the American Board of Internal Medicine. Dr. Nacev is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Liposarcoma, Synovial Sarcoma, and Fibrosarcoma.
West Virginia University Medical Corporation
Miklos Auber is a Hematologist Oncology specialist and a Hematologist in Morgantown, West Virginia. Dr. Auber is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Fibrosarcoma, Bone Tumor, Myxoid Liposarcoma, Epithelioid Sarcoma, and Bone Marrow Aspiration. Dr. Auber is currently accepting new patients.
UPMC Department Of Urology
Ronald L. Hrebinko, MD, is a professor of urology at the University of Pittsburgh School of Medicine. He specializes in all genitourinary cancers with special expertise in continent urinary diversion, nephron-sparing surgery for renal cancer, laparoscopic kidney surgery, nerve-sparing surgery for the prostate, and testis cancer. Dr. Hrebinko is board-certified in urology. He received an undergraduate degree with honors from Dartmouth College in N.H., and a medical degree at the University of Pittsburgh School of Medicine. Dr. Hrebinko completed a residency at UPMC in the Department of Surgery, and a fellowship at Roswell Park Cancer Institute, in Buffalo, N.Y. Dr. Hrebinko is a member of professional organizations, such as the American Urologic Association, Society of Urologic Oncology, and the American Society of Clinical Oncology. Are you already a patient of this provider and have a MyUPMC account? Log in to MyUPMC to schedule. Dr. Hrebinko is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Clear Cell Sarcoma, Wilms Tumor, Nephrectomy, and Reconstructive Urology Surgery.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Adult Soft Tissue SarcomaDr. Hogan isDistinguished. Learn about Adult Soft Tissue Sarcoma.
- Chromophobe Renal Cell CarcinomaDr. Hogan isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Hogan isDistinguished. Learn about Clear Cell Sarcoma.
- Familial Prostate CancerDr. Hogan isDistinguished. Learn about Familial Prostate Cancer.
- Familial Wilms Tumor 2Dr. Hogan isDistinguished. Learn about Familial Wilms Tumor 2.
- Muscle Invasive Bladder CancerDr. Hogan isDistinguished. Learn about Muscle Invasive Bladder Cancer.
- Advanced
- Adrenal CancerDr. Hogan isAdvanced. Learn about Adrenal Cancer.
- Adrenocortical CarcinomaDr. Hogan isAdvanced. Learn about Adrenocortical Carcinoma.
- Bladder CancerDr. Hogan isAdvanced. Learn about Bladder Cancer.
- Familial Colorectal CancerDr. Hogan isAdvanced. Learn about Familial Colorectal Cancer.
- MethemoglobinemiaDr. Hogan isAdvanced. Learn about Methemoglobinemia.
- Upper Tract Urothelial Carcinoma (UTUC)
- Experienced
- 2q37 Deletion SyndromeDr. Hogan isExperienced. Learn about 2q37 Deletion Syndrome.
- 47 XYY SyndromeDr. Hogan isExperienced. Learn about 47 XYY Syndrome.
- Aase SyndromeDr. Hogan isExperienced. Learn about Aase Syndrome.
- Abruzzo-Erickson SyndromeDr. Hogan isExperienced. Learn about Abruzzo-Erickson Syndrome.
- Acrodermatitis EnteropathicaDr. Hogan isExperienced. Learn about Acrodermatitis Enteropathica.
- Acrorenal Mandibular SyndromeDr. Hogan isExperienced. Learn about Acrorenal Mandibular Syndrome.